About This Event

Axsome Therapeutics (Nasdaq: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, visits the Nasdaq MarketSite in Times Square to ring the opening bell of the Nasdaq Stock Market to highlight its Frontiers in Brain Health R&D Day event being held today.

In honor of the occasion, Herriot Tabuteau, MD, CEO, rings the Opening Bell along with the rest of the management team and other Axsome team members.